-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In January this year, the new version of the National Medical Insurance Drug Catalog was implemented, and the nationally negotiated drugs have been equipped in more than 150,000 designated medical institutions across the country
.
.
Mr.
Xie, a citizen of Huzhou, Zhejiang Province, purchased a drug for national medical insurance negotiation in a retail pharmacy, which is a targeted drug for the treatment of malignant tumors
.
Xie, a citizen of Huzhou, Zhejiang Province, purchased a drug for national medical insurance negotiation in a retail pharmacy, which is a targeted drug for the treatment of malignant tumors
.
On January 1 this year, the new version of the National Medical Insurance Catalog was implemented, and 67 new drugs were added through negotiation, with an average price reduction of 62%, covering the needs for drugs such as tumors, chronic diseases, and rare diseases
.
To reduce the burden of medicines on the masses, not only the medicines can be covered by medical insurance and "reimbursable", but also to allow the masses to use medicines conveniently and quickly, and to improve the availability of negotiated medicines
.
In order to solve the problem of negotiating drug delivery, in May last year, the National Medical Insurance Bureau proposed a "dual-channel" management mechanism for negotiated drugs, determined to include designated retail pharmacies in the scope of medical insurance drug supply guarantees, and implemented a unified payment policy with medical institutions
.
As of the end of February 2022, the negotiated drugs during the agreement period in the new version of the National Medical Insurance Drug List will be available in 154,700 designated medical institutions across the country, including 42,100 designated medical institutions and 112,600 designated retail pharmacies , respectively
.
.
To reduce the burden of medicines on the masses, not only the medicines can be covered by medical insurance and "reimbursable", but also to allow the masses to use medicines conveniently and quickly, and to improve the availability of negotiated medicines
.
In order to solve the problem of negotiating drug delivery, in May last year, the National Medical Insurance Bureau proposed a "dual-channel" management mechanism for negotiated drugs, determined to include designated retail pharmacies in the scope of medical insurance drug supply guarantees, and implemented a unified payment policy with medical institutions
.
As of the end of February 2022, the negotiated drugs during the agreement period in the new version of the National Medical Insurance Drug List will be available in 154,700 designated medical institutions across the country, including 42,100 designated medical institutions and 112,600 designated retail pharmacies , respectively
.
According to the National Medical Insurance Administration, in January this year alone, 17.
7387 million drug reimbursements were negotiated during the agreement period, and the medical insurance fund expenditure was 5.
197 billion yuan, with an average actual reimbursement ratio of 69.
12%
.
7387 million drug reimbursements were negotiated during the agreement period, and the medical insurance fund expenditure was 5.
197 billion yuan, with an average actual reimbursement ratio of 69.
12%
.
Since 2018, a total of 6 batches of state-organized drug centralized procurement have been carried out , and a total of 234 kinds of drugs have been purchased.
The amount involved accounts for 30% of the total annual purchase of chemical drugs by public medical institutions.
Calculated based on the pre-purchased amount, the cumulative cost savings is 2,600 yuan.
billions or more
.
The amount involved accounts for 30% of the total annual purchase of chemical drugs by public medical institutions.
Calculated based on the pre-purchased amount, the cumulative cost savings is 2,600 yuan.
billions or more
.
In January this year, the new version of the National Medical Insurance Drug Catalog was implemented, and the nationally negotiated drugs have been equipped in more than 150,000 designated medical institutions across the country
.
.
Mr.
Xie, a citizen of Huzhou, Zhejiang Province, purchased a drug for national medical insurance negotiation in a retail pharmacy, which is a targeted drug for the treatment of malignant tumors
.
Xie, a citizen of Huzhou, Zhejiang Province, purchased a drug for national medical insurance negotiation in a retail pharmacy, which is a targeted drug for the treatment of malignant tumors
.
On January 1 this year, the new version of the National Medical Insurance Catalog was implemented, and 67 new drugs were added through negotiation, with an average price reduction of 62%, covering the needs for drugs such as tumors, chronic diseases, and rare diseases
.
To reduce the burden of medicines on the masses, not only the medicines can be covered by medical insurance and "reimbursable", but also to allow the masses to use medicines conveniently and quickly, and to improve the availability of negotiated medicines
.
In order to solve the problem of negotiating drug delivery, in May last year, the National Medical Insurance Bureau proposed a "dual-channel" management mechanism for negotiated drugs, determined to include designated retail pharmacies in the scope of medical insurance drug supply guarantees, and implemented a unified payment policy with medical institutions
.
As of the end of February 2022, the negotiated drugs during the agreement period in the new version of the National Medical Insurance Drug List will be available in 154,700 designated medical institutions across the country, including 42,100 designated medical institutions and 112,600 designated retail pharmacies , respectively
.
.
To reduce the burden of medicines on the masses, not only the medicines can be covered by medical insurance and "reimbursable", but also to allow the masses to use medicines conveniently and quickly, and to improve the availability of negotiated medicines
.
In order to solve the problem of negotiating drug delivery, in May last year, the National Medical Insurance Bureau proposed a "dual-channel" management mechanism for negotiated drugs, determined to include designated retail pharmacies in the scope of medical insurance drug supply guarantees, and implemented a unified payment policy with medical institutions
.
As of the end of February 2022, the negotiated drugs during the agreement period in the new version of the National Medical Insurance Drug List will be available in 154,700 designated medical institutions across the country, including 42,100 designated medical institutions and 112,600 designated retail pharmacies , respectively
.
According to the National Medical Insurance Administration, in January this year alone, 17.
7387 million drug reimbursements were negotiated during the agreement period, and the medical insurance fund expenditure was 5.
197 billion yuan, with an average actual reimbursement ratio of 69.
12%
.
7387 million drug reimbursements were negotiated during the agreement period, and the medical insurance fund expenditure was 5.
197 billion yuan, with an average actual reimbursement ratio of 69.
12%
.
Since 2018, a total of 6 batches of state-organized drug centralized procurement have been carried out , and a total of 234 kinds of drugs have been purchased.
The amount involved accounts for 30% of the total annual purchase of chemical drugs by public medical institutions.
Calculated based on the pre-purchased amount, the cumulative cost savings is 2,600 yuan.
billions or more
.
The amount involved accounts for 30% of the total annual purchase of chemical drugs by public medical institutions.
Calculated based on the pre-purchased amount, the cumulative cost savings is 2,600 yuan.
billions or more
.
In January this year, the new version of the National Medical Insurance Drug Catalog was implemented, and the nationally negotiated drugs have been equipped in more than 150,000 designated medical institutions across the country
.
.
Mr.
Xie, a citizen of Huzhou, Zhejiang Province, purchased a drug for national medical insurance negotiation in a retail pharmacy, which is a targeted drug for the treatment of malignant tumors
.
tumor tumor tumorXie, a citizen of Huzhou, Zhejiang Province, purchased a drug for national medical insurance negotiation in a retail pharmacy, which is a targeted drug for the treatment of malignant tumors
.
On January 1 this year, the new version of the National Medical Insurance Catalog was implemented, and 67 new drugs were added through negotiation, with an average price reduction of 62%, covering the needs for drugs such as tumors, chronic diseases, and rare diseases
.
To reduce the burden of medicines on the masses, not only the medicines can be covered by medical insurance and "reimbursable", but also to allow the masses to use medicines conveniently and quickly, and to improve the availability of negotiated medicines
.
In order to solve the problem of negotiating drug delivery, in May last year, the National Medical Insurance Bureau proposed a "dual-channel" management mechanism for negotiated drugs, determined to include designated retail pharmacies in the scope of medical insurance drug supply guarantees, and implemented a unified payment policy with medical institutions
.
As of the end of February 2022, the negotiated drugs during the agreement period in the new version of the National Medical Insurance Drug List will be available in 154,700 designated medical institutions across the country, including 42,100 designated medical institutions and 112,600 designated retail pharmacies , respectively
.
Medicines Medicines Medicines Medicines Medicines Medicines Pharmacies Pharmacies Pharmacies.
To reduce the burden of medicines on the masses, not only the medicines can be covered by medical insurance and "reimbursable", but also to allow the masses to use medicines conveniently and quickly, and to improve the availability of negotiated medicines
.
In order to solve the problem of negotiating drug delivery, in May last year, the National Medical Insurance Bureau proposed a "dual-channel" management mechanism for negotiated drugs, determined to include designated retail pharmacies in the scope of medical insurance drug supply guarantees, and implemented a unified payment policy with medical institutions
.
As of the end of February 2022, the negotiated drugs during the agreement period in the new version of the National Medical Insurance Drug List will be available in 154,700 designated medical institutions across the country, including 42,100 designated medical institutions and 112,600 designated retail pharmacies , respectively
.
According to the National Medical Insurance Administration, in January this year alone, 17.
7387 million drug reimbursements were negotiated during the agreement period, and the medical insurance fund expenditure was 5.
197 billion yuan, with an average actual reimbursement ratio of 69.
12%
.
7387 million drug reimbursements were negotiated during the agreement period, and the medical insurance fund expenditure was 5.
197 billion yuan, with an average actual reimbursement ratio of 69.
12%
.
Since 2018, a total of 6 batches of state-organized drug centralized procurement have been carried out , and a total of 234 kinds of drugs have been purchased.
The amount involved accounts for 30% of the total annual purchase of chemical drugs by public medical institutions.
Calculated based on the pre-purchased amount, the cumulative cost savings is 2,600 yuan.
billions or more
.
purchase purchase purchase The amount involved accounts for 30% of the total annual purchase of chemical drugs by public medical institutions.
Calculated based on the pre-purchased amount, the cumulative cost savings is 2,600 yuan.
billions or more
.
